NEW YORK, NY / ACCESSWIRE / April 8, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against the Board of Directors of Merit Medical Systems, Inc. ("Merit Medical" or "the Company") (NASDAQ:MMSI) for possible breaches of fiduciary duty. Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/mmsi.
On March 29, 2021, Judge David O. Carter of the United States District Court for the Central District of California denied the defendants’ motion to dismiss in the securities class action for alleged violations of the Securities Exchange Act of 1934. The complaint alleges that during the class period of February 26, 2019 through October 30, 2019, Merit Medical executives issued false and misleading statements to investors regarding its integration of acquired companies, its product pipeline, and its prospects and financial guidance.
If you are a current Merit Medical shareholder and you have held your shares since January 2019, you can learn more about the investigation by visiting the firm's site: www.bgandg.com/name. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | [email protected]
SOURCE: Bronstein, Gewirtz & Grossman, LLC